Neurodiagnostics Market Expected to Exceed USD 14.03 Billion by 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neurodiagnostics Market Size, Share & Trends Analysis Report By Product (Diagnostic and Imaging Systems, Clinical Testing Instruments, Reagents & Consumables), By Condition (Neuro Degenerative Diseases, Epilepsy, Stroke), By End-Use (surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, and research laboratories & academic institutes)- Market Outlook And Industry Analysis 2031"

The global neurodiagnostic market is estimated to reach over USD 14.03 billion by 2031, exhibiting a CAGR of 7.12% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1683

Diagnostic tests are critical instruments in the diagnosis of neurological illnesses. Neuroimaging technologies, in vitro diagnostics, and neuroinformatics are the three segments of the neurodiagnostic market. Imaging techniques used in neuroimaging include computed tomography, magnetic resonance imaging, electroencephalography, and magneto-encephalography, among others. Conventional diagnostic therapies do not allow for early and reliable diagnosis, resulting in a strong demand for technologically enhanced diagnostic platforms. The global elderly population is continually expanding as life expectancy rises.
Neurological illnesses associated with aging, such as stroke, Alzheimer's disease, Parkinson's disease, and dementia, are also growing in frequency and prevalence. Moreover, with the increasing prevalence of neurological diseases worldwide, governments and non-governmental organizations are investing heavily in the development of diagnostics and therapeutics for treatment, as well as increasing funding and awareness programs for various neurological disorders, which may augment market growth.